View Mobile Friendly Conference List »

Conference Forum Blogs Posts


Podcast: Cell & Gene Therapy Day Overview in 4 minutes

In this podcast, Kate Woda, Conference Director provides an overview of Cell & Gene Therapy Day in less than 4 minutes. Cell & Gene Therapy Day takes place on February 27, 2020 in New York City and convenes stakeholders spanning the science and business communities to report on the latest cell and gene therapy progress to fight […]

Read More »

Fireside Chat with an R&D Veteran

Dr Jeffrey Chodakewitz, former EVP, Clinical Medicine and External Innovation, CMO at Vertex Pharmaceuticals, joins the Chief Medical Officer Summit for the first time to discuss his incredible journey as a CMO. Recorded at the 7th annual Chief Medical Officer Summit, Dr Chodakewitz sits down with Dr Julie Krop, AMAG Pharmaceuticals to discuss the following: […]

Read More »

Workforce Readiness: Cultures, Tools and Skills Needed by Organizations and Employees to Drive Innovation in Drug Development

Drug development innovation requires not only creative solutions but also a workforce ready and able to embrace new approaches. The Innovation Imperative: The Future of Drug Development, a report by the Economist Intelligence Unit (EIU) and commissioned by Parexel, found that inadequate workforce readiness is a major challenge to innovation in the pharmaceutical industry 1 […]

Read More »

Podcast: 2020 Immuno-Oncology 360° Summit Overview in 10 Minutes

In this 10 minute podcast, Kate Woda, Conference Director for IO360°, walks you through what to expect at 2020 IO360° Summit happening February 26-28, 2020 in New York City. IO360°convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. The 6th annual IO360° […]

Read More »

Patients Helping Pharma @ Patients as Partners Europe

At the 2020 Patients as Partners Europe summit, patients experienced in clinical trials take center stage to help industry understand how to incorporate their voices to create greater efficiencies in clinical research.The 4th annual summit will take place January 27-28, 2020, at the Millennium Gloucester Hotel in London.  Patient advocate Lesley Gosden is the summit’s […]

Read More »

Penn Medicine’s Recent Cancer Immunotherapy Blog Post Features Several IO360˚ Speakers

We are delighted to see so many IO360˚ speakers mentioned in the Abramson Cancer Center’s recent blog post, including Dr Carl June, Dr Stephan Grupp, Dr Bruce Levine and Dr Marco Ruella. The blog post reviews their progress since August 30, 2017, when the FDA decided to approve the first cellular therapy treatment, now known […]

Read More »

How do Patients Become Partners in the Sharing of Data to Advance Science?

In this podcast, hear a session from the 2019 Patients as Partners EU conference on How do Patients Become Partners in the Sharing of Data to Advance Science? How to encourage the sharing of suitably anonymized data to further medicines development for the benefit of patients? What are the barriers/issues? Public mistrust of pharma? Language, medical […]

Read More »

Best Practices for Pharma – Patient Advocacy Partnerships

In this podcast, hear a panel discussion presented at the 2019 Patients as Partners EU conference on Best Practices for Pharma – Patient Advocacy Partnerships.  Pharma and advocacy representatives discuss: • Advocacy point of view on is what pharma is doing in clinical trials and medicines development truly patient-centric? • How can advocacy groups work with the […]

Read More »

Designing Clinical Trials for Gene Therapy – A Paradigm Shift

This session, recorded at the 7th annual Chief Medical Officer Summit and moderated by Dr Martin Childers, Asklepios BioPharmaceutical, discusses designing clinical trials for gene therapy. Topics covered include: How to utilize adaptive trial design within the specific context of a gene therapy – are there any unique aspects of development conducive to this approach? […]

Read More »

Clinical update on AMG 420, an anti-BCMA BiTE®

In this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE® This talk addresses the: – Summary of IND enabling preclinical studies – First-in-human trial design – First-in-human trial data (safety, efficacy)              Save the date for the […]

Read More »